No profile data available.
Q32 Bio Inc. (QTTB) is a healthcare company in the skin treatment pharmaceuticals industry, based in Waltham, United States, with about 22 full-time employees.
It reported revenue of $53.74 million for fiscal year 2025, and net income of $29.82 million. Its market capitalization was $248.28 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction.
Q32 Bio reported $53.74 million in revenue for fiscal year 2025.
$248.28 million as of October 9, 2026.
Listed companies of a similar size in the same industry (skin treatment pharmaceuticals) include Evolus, Inc. (EOLS), Avalo Therapeutics, Inc. (AVTX), Abeona Therapeutics Inc. (ABEO), Sol-Gel Technologies Ltd. (SLGL).